Abstract
Summary
According to our LPI (LP Information) latest study, the global Biopharmaceuticals Contract Manufacturing market size was valued at US$ 85920 million in 2023. With growing demand in downstream market, the Biopharmaceuticals Contract Manufacturing is forecast to a readjusted size of US$ 119900 million by 2030 with a CAGR of 4.9% during review period.
The research report highlights the growth potential of the global Biopharmaceuticals Contract Manufacturing market. Biopharmaceuticals Contract Manufacturing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biopharmaceuticals Contract Manufacturing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biopharmaceuticals Contract Manufacturing market.
Contract manufacturing organization is a company that serve other companies in the biopharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biopharmaceuticals Contract Manufacturing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biopharmaceuticals Contract Manufacturing market. It may include historical data, market segmentation by Type (e.g., Biologics, Biosimilars), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biopharmaceuticals Contract Manufacturing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biopharmaceuticals Contract Manufacturing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biopharmaceuticals Contract Manufacturing industry. This include advancements in Biopharmaceuticals Contract Manufacturing technology, Biopharmaceuticals Contract Manufacturing new entrants, Biopharmaceuticals Contract Manufacturing new investment, and other innovations that are shaping the future of Biopharmaceuticals Contract Manufacturing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biopharmaceuticals Contract Manufacturing market. It includes factors influencing customer ' purchasing decisions, preferences for Biopharmaceuticals Contract Manufacturing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biopharmaceuticals Contract Manufacturing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biopharmaceuticals Contract Manufacturing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biopharmaceuticals Contract Manufacturing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biopharmaceuticals Contract Manufacturing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biopharmaceuticals Contract Manufacturing market.
Market Segmentation:
Biopharmaceuticals Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Biologics
Biosimilars
Segmentation by application
Process Development
Packaging
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.
The research report highlights the growth potential of the global Biopharmaceuticals Contract Manufacturing market. Biopharmaceuticals Contract Manufacturing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biopharmaceuticals Contract Manufacturing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biopharmaceuticals Contract Manufacturing market.
Contract manufacturing organization is a company that serve other companies in the biopharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biopharmaceuticals Contract Manufacturing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biopharmaceuticals Contract Manufacturing market. It may include historical data, market segmentation by Type (e.g., Biologics, Biosimilars), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biopharmaceuticals Contract Manufacturing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biopharmaceuticals Contract Manufacturing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biopharmaceuticals Contract Manufacturing industry. This include advancements in Biopharmaceuticals Contract Manufacturing technology, Biopharmaceuticals Contract Manufacturing new entrants, Biopharmaceuticals Contract Manufacturing new investment, and other innovations that are shaping the future of Biopharmaceuticals Contract Manufacturing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biopharmaceuticals Contract Manufacturing market. It includes factors influencing customer ' purchasing decisions, preferences for Biopharmaceuticals Contract Manufacturing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biopharmaceuticals Contract Manufacturing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biopharmaceuticals Contract Manufacturing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biopharmaceuticals Contract Manufacturing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biopharmaceuticals Contract Manufacturing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biopharmaceuticals Contract Manufacturing market.
Market Segmentation:
Biopharmaceuticals Contract Manufacturing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Biologics
Biosimilars
Segmentation by application
Process Development
Packaging
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biopharmaceuticals Contract Manufacturing Market Size 2019-2030
2.1.2 Biopharmaceuticals Contract Manufacturing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biopharmaceuticals Contract Manufacturing Segment by Type
2.2.1 Biologics
2.2.2 Biosimilars
2.3 Biopharmaceuticals Contract Manufacturing Market Size by Type
2.3.1 Biopharmaceuticals Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Biopharmaceuticals Contract Manufacturing Segment by Application
2.4.1 Process Development
2.4.2 Packaging
2.4.3 Others
2.5 Biopharmaceuticals Contract Manufacturing Market Size by Application
2.5.1 Biopharmaceuticals Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biopharmaceuticals Contract Manufacturing Market Size Market Share by Application (2019-2024)
3 Biopharmaceuticals Contract Manufacturing Market Size by Player
3.1 Biopharmaceuticals Contract Manufacturing Market Size Market Share by Players
3.1.1 Global Biopharmaceuticals Contract Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Biopharmaceuticals Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceuticals Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biopharmaceuticals Contract Manufacturing by Regions
4.1 Biopharmaceuticals Contract Manufacturing Market Size by Regions (2019-2024)
4.2 Americas Biopharmaceuticals Contract Manufacturing Market Size Growth (2019-2024)
4.3 APAC Biopharmaceuticals Contract Manufacturing Market Size Growth (2019-2024)
4.4 Europe Biopharmaceuticals Contract Manufacturing Market Size Growth (2019-2024)
4.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Biopharmaceuticals Contract Manufacturing Market Size by Country (2019-2024)
5.2 Americas Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024)
5.3 Americas Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biopharmaceuticals Contract Manufacturing Market Size by Region (2019-2024)
6.2 APAC Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024)
6.3 APAC Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biopharmaceuticals Contract Manufacturing by Country (2019-2024)
7.2 Europe Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024)
7.3 Europe Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biopharmaceuticals Contract Manufacturing Market Forecast
10.1 Global Biopharmaceuticals Contract Manufacturing Forecast by Regions (2025-2030)
10.1.1 Global Biopharmaceuticals Contract Manufacturing Forecast by Regions (2025-2030)
10.1.2 Americas Biopharmaceuticals Contract Manufacturing Forecast
10.1.3 APAC Biopharmaceuticals Contract Manufacturing Forecast
10.1.4 Europe Biopharmaceuticals Contract Manufacturing Forecast
10.1.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Forecast
10.2 Americas Biopharmaceuticals Contract Manufacturing Forecast by Country (2025-2030)
10.2.1 United States Biopharmaceuticals Contract Manufacturing Market Forecast
10.2.2 Canada Biopharmaceuticals Contract Manufacturing Market Forecast
10.2.3 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast
10.2.4 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast
10.3 APAC Biopharmaceuticals Contract Manufacturing Forecast by Region (2025-2030)
10.3.1 China Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.2 Japan Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.3 Korea Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.4 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.5 India Biopharmaceuticals Contract Manufacturing Market Forecast
10.3.6 Australia Biopharmaceuticals Contract Manufacturing Market Forecast
10.4 Europe Biopharmaceuticals Contract Manufacturing Forecast by Country (2025-2030)
10.4.1 Germany Biopharmaceuticals Contract Manufacturing Market Forecast
10.4.2 France Biopharmaceuticals Contract Manufacturing Market Forecast
10.4.3 UK Biopharmaceuticals Contract Manufacturing Market Forecast
10.4.4 Italy Biopharmaceuticals Contract Manufacturing Market Forecast
10.4.5 Russia Biopharmaceuticals Contract Manufacturing Market Forecast
10.5 Middle East & Africa Biopharmaceuticals Contract Manufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Biopharmaceuticals Contract Manufacturing Market Forecast
10.5.2 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast
10.5.3 Israel Biopharmaceuticals Contract Manufacturing Market Forecast
10.5.4 Turkey Biopharmaceuticals Contract Manufacturing Market Forecast
10.5.5 GCC Countries Biopharmaceuticals Contract Manufacturing Market Forecast
10.6 Global Biopharmaceuticals Contract Manufacturing Forecast by Type (2025-2030)
10.7 Global Biopharmaceuticals Contract Manufacturing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Information
11.1.2 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Product Offered
11.1.3 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Boehringer Ingelheim Main Business Overview
11.1.5 Boehringer Ingelheim Latest Developments
11.2 Lonza Group AG
11.2.1 Lonza Group AG Company Information
11.2.2 Lonza Group AG Biopharmaceuticals Contract Manufacturing Product Offered
11.2.3 Lonza Group AG Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Lonza Group AG Main Business Overview
11.2.5 Lonza Group AG Latest Developments
11.3 Inno Biologics Sdn Bhd
11.3.1 Inno Biologics Sdn Bhd Company Information
11.3.2 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Product Offered
11.3.3 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Inno Biologics Sdn Bhd Main Business Overview
11.3.5 Inno Biologics Sdn Bhd Latest Developments
11.4 Rentschler Biopharma
11.4.1 Rentschler Biopharma Company Information
11.4.2 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Product Offered
11.4.3 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Rentschler Biopharma Main Business Overview
11.4.5 Rentschler Biopharma Latest Developments
11.5 JRS Pharma
11.5.1 JRS Pharma Company Information
11.5.2 JRS Pharma Biopharmaceuticals Contract Manufacturing Product Offered
11.5.3 JRS Pharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 JRS Pharma Main Business Overview
11.5.5 JRS Pharma Latest Developments
11.6 AGC Biologics
11.6.1 AGC Biologics Company Information
11.6.2 AGC Biologics Biopharmaceuticals Contract Manufacturing Product Offered
11.6.3 AGC Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AGC Biologics Main Business Overview
11.6.5 AGC Biologics Latest Developments
11.7 ProBioGen
11.7.1 ProBioGen Company Information
11.7.2 ProBioGen Biopharmaceuticals Contract Manufacturing Product Offered
11.7.3 ProBioGen Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ProBioGen Main Business Overview
11.7.5 ProBioGen Latest Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Information
11.8.2 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Product Offered
11.8.3 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.8.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.9 Toyobo Co., Ltd.
11.9.1 Toyobo Co., Ltd. Company Information
11.9.2 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Offered
11.9.3 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Toyobo Co., Ltd. Main Business Overview
11.9.5 Toyobo Co., Ltd. Latest Developments
11.10 Samsung Biologics
11.10.1 Samsung Biologics Company Information
11.10.2 Samsung Biologics Biopharmaceuticals Contract Manufacturing Product Offered
11.10.3 Samsung Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Samsung Biologics Main Business Overview
11.10.5 Samsung Biologics Latest Developments
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Information
11.11.2 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Product Offered
11.11.3 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Thermo Fisher Scientific Main Business Overview
11.11.5 Thermo Fisher Scientific Latest Developments
11.12 Binex Co., Ltd.
11.12.1 Binex Co., Ltd. Company Information
11.12.2 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Offered
11.12.3 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Binex Co., Ltd. Main Business Overview
11.12.5 Binex Co., Ltd. Latest Developments
11.13 WuXi Biologics
11.13.1 WuXi Biologics Company Information
11.13.2 WuXi Biologics Biopharmaceuticals Contract Manufacturing Product Offered
11.13.3 WuXi Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 WuXi Biologics Main Business Overview
11.13.5 WuXi Biologics Latest Developments
11.14 AbbVie, Inc.
11.14.1 AbbVie, Inc. Company Information
11.14.2 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Product Offered
11.14.3 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 AbbVie, Inc. Main Business Overview
11.14.5 AbbVie, Inc. Latest Developments
12 Research Findings and Conclusion